Ruggeri, M <br/><br/>
Economic Analysis and Budget Impact of Tenofovir and Entecavir in the First-Line Treatment of Hepatitis B Virus in Italy.  [electronic resource] 

 -  Applied health economics and health policy  Aug 2017 
 - 479-490 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1179-1896 
<br/><br/><label>Standard No.: </label>10.1007/s40258-017-0311-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antiviral Agents--economics<br/>Cost-Benefit Analysis<br/>Guanine--analogs & derivatives<br/>Health Care Costs--statistics & numerical data<br/>Hepatitis B, Chronic--drug therapy<br/>Humans<br/>Italy--epidemiology<br/>Markov Chains<br/>Quality-Adjusted Life Years<br/>Tenofovir--economics<br/>Treatment Outcome